Ectica Technologies

Ectica Technologies AG is a Swiss life science company dedicated to advancing technologies for research and drug discovery tailored for pre-clinical contract research organizations (CROs) and biopharma companies. Our core competence lies in developing sophisticated in vitro and ex vivo stromal models that address intricate challenges in oncology, fibrosis, and tissue regeneration. We extend our expertise to contract development and manufacturing organizations (CDMOs) seeking tailored hydrogel formulations. The company’s patented 3DProSeed™ technology combines the biological relevance of hydrogel-based cultures with highest levels of workflow integration levels in drug discovery. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It engages in contract development and production of original equipment manufacturer (OEM) solutions, which can be customised in terms of hydrogel chemistry, product format, usage and branding.